Antipsychotic polypharmacy in a regional health service: a population-based study

<p>Abstract</p> <p>Background</p> <p>To analyse the extent and profile of outpatient regular dispensation of antipsychotics, both in combination and monotherapy, in the Barcelona Health Region (Spain), focusing on the use of clozapine and long-acting injections (LAI).&l...

Full description

Bibliographic Details
Main Authors: Bernardo Miguel, Coma Anna, Ibáñez Cristina, Zara Corinne, Bari Josep, Serrano-Blanco Antoni
Format: Article
Language:English
Published: BMC 2012-05-01
Series:BMC Psychiatry
Subjects:
Online Access:http://www.biomedcentral.com/1471-244X/12/42
_version_ 1818919564936740864
author Bernardo Miguel
Coma Anna
Ibáñez Cristina
Zara Corinne
Bari Josep
Serrano-Blanco Antoni
author_facet Bernardo Miguel
Coma Anna
Ibáñez Cristina
Zara Corinne
Bari Josep
Serrano-Blanco Antoni
author_sort Bernardo Miguel
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>To analyse the extent and profile of outpatient regular dispensation of antipsychotics, both in combination and monotherapy, in the Barcelona Health Region (Spain), focusing on the use of clozapine and long-acting injections (LAI).</p> <p>Methods</p> <p>Antipsychotic drugs dispensed for people older than 18 and processed by the Catalan Health Service during 2007 were retrospectively reviewed. First and second generation antipsychotic drugs (FGA and SGA) from the Anatomical Therapeutic Chemical classification (ATC) code N05A (except lithium) were included. A patient selection algorithm was designed to identify prescriptions regularly dispensed. Variables included were age, gender, antipsychotic type, route of administration and number of packages dispensed.</p> <p>Results</p> <p>A total of 117,811 patients were given any antipsychotic, of whom 71,004 regularly received such drugs. Among the latter, 9,855 (13.9%) corresponded to an antipsychotic combination, 47,386 (66.7%) to monotherapy and 13,763 (19.4%) to unspecified combinations. Of the patients given antipsychotics in association, 58% were men. Olanzapine (37.1%) and oral risperidone (36.4%) were the most common dispensations. Analysis of the patients dispensed two antipsychotics (57.8%) revealed 198 different combinations, the most frequent being the association of FGA and SGA (62.0%). Clozapine was dispensed to 2.3% of patients. Of those who were receiving antipsychotics in combination, 6.6% were given clozapine, being clozapine plus amisulpride the most frequent association (22.8%). A total of 3.800 patients (5.4%) were given LAI antipsychotics, and 2.662 of these (70.1%) were in combination. Risperidone was the most widely used LAI.</p> <p>Conclusions</p> <p>The scant evidence available regarding the efficacy of combining different antipsychotics contrasts with the high number and variety of combinations prescribed to outpatients, as well as with the limited use of clozapine.</p>
first_indexed 2024-12-20T01:07:52Z
format Article
id doaj.art-dd13155f81e941689f921da5f3833a32
institution Directory Open Access Journal
issn 1471-244X
language English
last_indexed 2024-12-20T01:07:52Z
publishDate 2012-05-01
publisher BMC
record_format Article
series BMC Psychiatry
spelling doaj.art-dd13155f81e941689f921da5f3833a322022-12-21T19:58:47ZengBMCBMC Psychiatry1471-244X2012-05-011214210.1186/1471-244X-12-42Antipsychotic polypharmacy in a regional health service: a population-based studyBernardo MiguelComa AnnaIbáñez CristinaZara CorinneBari JosepSerrano-Blanco Antoni<p>Abstract</p> <p>Background</p> <p>To analyse the extent and profile of outpatient regular dispensation of antipsychotics, both in combination and monotherapy, in the Barcelona Health Region (Spain), focusing on the use of clozapine and long-acting injections (LAI).</p> <p>Methods</p> <p>Antipsychotic drugs dispensed for people older than 18 and processed by the Catalan Health Service during 2007 were retrospectively reviewed. First and second generation antipsychotic drugs (FGA and SGA) from the Anatomical Therapeutic Chemical classification (ATC) code N05A (except lithium) were included. A patient selection algorithm was designed to identify prescriptions regularly dispensed. Variables included were age, gender, antipsychotic type, route of administration and number of packages dispensed.</p> <p>Results</p> <p>A total of 117,811 patients were given any antipsychotic, of whom 71,004 regularly received such drugs. Among the latter, 9,855 (13.9%) corresponded to an antipsychotic combination, 47,386 (66.7%) to monotherapy and 13,763 (19.4%) to unspecified combinations. Of the patients given antipsychotics in association, 58% were men. Olanzapine (37.1%) and oral risperidone (36.4%) were the most common dispensations. Analysis of the patients dispensed two antipsychotics (57.8%) revealed 198 different combinations, the most frequent being the association of FGA and SGA (62.0%). Clozapine was dispensed to 2.3% of patients. Of those who were receiving antipsychotics in combination, 6.6% were given clozapine, being clozapine plus amisulpride the most frequent association (22.8%). A total of 3.800 patients (5.4%) were given LAI antipsychotics, and 2.662 of these (70.1%) were in combination. Risperidone was the most widely used LAI.</p> <p>Conclusions</p> <p>The scant evidence available regarding the efficacy of combining different antipsychotics contrasts with the high number and variety of combinations prescribed to outpatients, as well as with the limited use of clozapine.</p>http://www.biomedcentral.com/1471-244X/12/42AntipsychoticsClozapineAntipsychotic combinationOutpatient setting
spellingShingle Bernardo Miguel
Coma Anna
Ibáñez Cristina
Zara Corinne
Bari Josep
Serrano-Blanco Antoni
Antipsychotic polypharmacy in a regional health service: a population-based study
BMC Psychiatry
Antipsychotics
Clozapine
Antipsychotic combination
Outpatient setting
title Antipsychotic polypharmacy in a regional health service: a population-based study
title_full Antipsychotic polypharmacy in a regional health service: a population-based study
title_fullStr Antipsychotic polypharmacy in a regional health service: a population-based study
title_full_unstemmed Antipsychotic polypharmacy in a regional health service: a population-based study
title_short Antipsychotic polypharmacy in a regional health service: a population-based study
title_sort antipsychotic polypharmacy in a regional health service a population based study
topic Antipsychotics
Clozapine
Antipsychotic combination
Outpatient setting
url http://www.biomedcentral.com/1471-244X/12/42
work_keys_str_mv AT bernardomiguel antipsychoticpolypharmacyinaregionalhealthserviceapopulationbasedstudy
AT comaanna antipsychoticpolypharmacyinaregionalhealthserviceapopulationbasedstudy
AT ibanezcristina antipsychoticpolypharmacyinaregionalhealthserviceapopulationbasedstudy
AT zaracorinne antipsychoticpolypharmacyinaregionalhealthserviceapopulationbasedstudy
AT barijosep antipsychoticpolypharmacyinaregionalhealthserviceapopulationbasedstudy
AT serranoblancoantoni antipsychoticpolypharmacyinaregionalhealthserviceapopulationbasedstudy